Vous avez cherché: adcs (Suédois - Anglais)

adcs-cgic
0.0072

och adcs-adl
cgic and adcs-adl

adcs- cgic exelon
adcs- cgic exelon

försämring enligt adcs-cgic
with no worsening on adcs-

adcs-adl tyder på förbättring.
positive adcs-adl changes indicate improvement.

p- värde jämfört med placebo adcs- adl
the results for clinically relevant responders from the 24-week study are provided in table 3.

adcs- cgic- poäng < 4 tyder på förbättring.
itt-locf population at least 4 points improvement on adas-cog with no worsening on adcs- cgic and adcs-adl

en ändring i positiv riktning av adcs-adl tyder på förbättring.
positive adcs-adl changes indicate improvement.

adcs-iadl scores: en positiv skillnad i dlsm indikerar större förbättring med exelon 15 cm2 jämfört med exelon 10 cm2.
adcs-iadl scores: a positive difference in dlsm indicates greater improvement in exelon 15 cm2 as compared to exelon 10 cm2.

studien visade fördelaktig effekt för memantinbehandling jämfört med placebobehandling vid 6 månader (observed cases analys avseende cibic-plus (clinician's interview based impression of change)): p=0,025; adcs-adlsev (alzheimer's disease cooperative study - activities of daily living): p=0,003; sib (severe impairment battery): p=0,002).
the study showed beneficial effects of memantine treatment in comparison to placebo at 6 months (observed cases analysis for the clinician´s interview based impression of change (cibic-plus): p = 0.025; alzheimer’s disease cooperative study – activities of daily living (adcs-adlsev): p = 0.003; severe impairment battery (sib): p = 0.002).